Cabozantinib capsule indications
The indications of cabozantinib capsules mainly include the treatment of various types of cancer.
Cabotinib capsules are widely used to treat metastatic medullary thyroid cancer (MTC). Cabozantinib has become an important treatment option, particularly for patients who cannot tolerate radioactive iodine therapy or whose disease has progressed to unresectable, locally advanced, or metastatic disease. The recommended dose is 140 mg per day. It inhibits the activity of multiple tyrosine kinases to control disease progression.

Cabozantinib has also demonstrated significant therapeutic efficacy in patients with advanced renal cell carcinoma (RCC) who have received anti-angiogenic therapy. Especially when patients are intolerant or ineffective of other treatments, cabozantinib can provide a new treatment approach. Usage and Dosage The recommended dose for the treatment of kidney cancer is 60 mg per day.
In the treatment of liver cancer, cabozantinib has a significant effect on patients with advanced hepatocellular carcinoma who have progressed after receiving other standard systemic treatments such as lenvatinib (lenvatinib) and sorafenib. Cabozantinib's multi-target inhibitory effect gives it great advantages in the treatment of complex and changeable liver cancer. The recommended dose for liver cancer is also 60 mg per day.
Cabozantinib has also shown potential therapeutic effects in a variety of other tumor types, such as prostate cancer, non-small cell lung cancer, colon cancer, etc. This is due to the unique mechanism of action of cabozantinib, which can inhibit a variety of tyrosine kinase receptors including RET, MET, VEGFR, KIT, etc. These receptors play a key role in the occurrence, development and metastasis of tumors.
However, it is worth noting that although cabozantinib has shown significant efficacy in the treatment of various cancers, it may also cause some side effects, such as diarrhea, gastritis, hand-foot syndrome, etc. Therefore, when using cabozantinib for treatment, it is necessary to strictly follow the doctor's instructions and pay close attention to the patient's response and condition.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)